AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE
Toronto, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the […]
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting
NAPANEE, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to announce […]
Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
BOCA RATON, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), […]
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or […]
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital […]
ATHA Energy Announces Latitude Uranium Obtains Shareholder Approval for Transaction
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is […]
Latitude Uranium Announces Voting Results from Special Meeting
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE: LUR, OTCQB: LURAF, […]
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) […]
Lancaster Resources Acquires High-Impact Uranium Claims in Athabasca Basin
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTCQB:LANRF) (FRA:6UF) (“Lancaster”), Lancaster Resources, a North […]
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) […]
